Connection

HUSSEIN TAWBI to Proto-Oncogene Proteins c-met

This is a "connection" page, showing publications HUSSEIN TAWBI has written about Proto-Oncogene Proteins c-met.
Connection Strength

0.158
  1. Phase 1 study of safety, pharmacokinetics, and pharmacodynamics of tivantinib in combination with bevacizumab in adult patients with advanced solid tumors. Cancer Chemother Pharmacol. 2021 10; 88(4):643-654.
    View in: PubMed
    Score: 0.158
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.